This is a critical point, since SCA2 is the subtype of SCA that is most commonly associated with levodopa-responsive Parkinson's disease (PD) and atypical parkinsonism worldwide (Gwinn-Hardy et al., 2000; Shan et al., 2001; Park et al., 2015). Here, ATXN2 is linked to Parkinson disease.